From discovery to diagnosis, the HALO® suite supports the full digital pathology journey. Indica Labs delivers AI-powered solutions spanning life science research, translational science, pharmaceutical development, companion diagnostics, and clinical deployment. Today, HALO has surpassed 3,000 deployments across 35 countries and six continents, supporting all 20 of the world’s top pharmaceutical companies and research cited in more than 2,600 peer-reviewed publications. That global research footprint is increasingly translating into clinical adoption, with HALO AP® clinical revenue growing 260% since 2023 and recurring clinical revenue increasing 200% year-over-year in 2025. From HALO®, HALO AI, and HALO Link to HALO AP® (CE-IVDR marked) and HALO AP Dx (FDA 510k cleared), one connected ecosystem helps bridge discovery, development, validation, and clinical implementation. One HALO ecosystem. From life science discovery to clinical deployment.